Effects of siRNA targeting BMPR-II on the biological activities of human liver cancer cells and its mechanism.

Zeng, Peng; Cai, Sheng; Zhang, Jia-Na; Yi, Feng-Ming; Jiang, Wei-Min; Wu, Jian-Bing

Zeng, Peng; Cai, Sheng; Zhang, Jia-Na; Yi, Feng-Ming; Jiang, Wei-Min; Wu, Jian-Bing.

Affiliation

Zeng P; Department of Oncology, the Second Affiliated Hospital, Nanchang University, Nanchang 330006, China ; Key Laboratory of Molecular Medicine Jiangxi Province, Nanchang 330006, China.
Cai S; Department of Oncology, the Second Affiliated Hospital, Nanchang University, Nanchang 330006, China ; Key Laboratory of Molecular Medicine Jiangxi Province, Nanchang 330006, China.
Zhang JN; Department of Pathology, the Second Affiliated Hospital, Nanchang University, Nanchang 330006, China ; Key Laboratory of Molecular Medicine Jiangxi Province, Nanchang 330006, China.
Yi FM; Department of Oncology, the Second Affiliated Hospital, Nanchang University, Nanchang 330006, China.
Jiang WM; Department of Oncology, the Second Affiliated Hospital, Nanchang University, Nanchang 330006, China.
Wu JB; Department of Oncology, the Second Affiliated Hospital, Nanchang University, Nanchang 330006, China ; One number, Minde Road, Nanchang City, Jiangxi Province, China.

Cancer Cell Int ; 14: 55, 2014.

Article de En | MEDLINE | ID: mdl-25002834

Mots clés

Bone morphogenetic protein receptor II; Liver cancer; Mitogen-activated protein kinases; Small interfering RNA; Vascular endothelial growth factor-C

Texte intégral

Ajouter à My VHL

Imprimer

XML

PubMed Links

Recherche sur Google

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Langue: En Journal: Cancer Cell Int Année: 2014 Type de document: Article Pays d'affiliation: Chine Pays de publication: Royaume-Uni

Texte intégral

Ajouter à My VHL

Imprimer

XML

PubMed Links

Recherche sur Google